Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury (Q45194633)
Jump to navigation
Jump to search
scientific article published on 11 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury |
scientific article published on 11 February 2009 |
Statements
1 reference
Anatibant, a selective non-peptide bradykinin B2 receptor antagonist, reduces intracranial hypertension and histopathological damage after experimental traumatic brain injury (English)
1 reference
Klaus Zweckberger
1 reference
Nikolaus Plesnila
1 reference
11 February 2009
1 reference
1 reference
454
1 reference
2
1 reference
115-117
1 reference
Identifiers
1 reference
1 reference